v3.25.1
Cover - USD ($)
12 Months Ended
Dec. 31, 2024
Mar. 11, 2025
Jun. 30, 2024
Cover [Abstract]      
Document Type 10-K/A    
Amendment Flag true    
Amendment Description On March 25, 2025, Immix Biopharma, Inc. filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the “Original Form 10-K”) with the U.S. Securities and Exchange Commission (the “SEC”). The Original Form 10-K failed to include certain required inline XBRL tagging which was inadvertently omitted in the Original Form 10-K, and this Amendment No. 1 to Annual Report on Form 10-K (“Amendment No. 1”) is being filed solely to include such inline XBRL tagging under Item 1C. Cybersecurity.  As such, this Amendment No. 1:     ● restates Part I, Item 1C (Cybersecurity), of the Original Form 10-K to include the required XBRL tagging; and         ● files new certifications of our principal executive officer and principal financial officer as exhibits to this Amendment under Item 15 of Part IV hereof, pursuant to Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).   This Amendment No. 1 does not otherwise change or update any of the disclosures set forth in the Original Form 10-K, and, except as expressly stated herein, does not reflect events occurring after the filing of the Original Form 10-K.      
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2024    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2024    
Current Fiscal Year End Date --12-31    
Entity File Number 001-41159    
Entity Registrant Name IMMIX BIOPHARMA, INC.    
Entity Central Index Key 0001873835    
Entity Tax Identification Number 45-4869378    
Entity Incorporation, State or Country Code DE    
Entity Address, Address Line One 11400 West Olympic Blvd.    
Entity Address, Address Line Two  Suite 200    
Entity Address, City or Town  Los Angeles    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 90064    
City Area Code (310)    
Local Phone Number 651-8041    
Title of 12(b) Security Common stock, $0.0001 par value    
Trading Symbol IMMX    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Elected Not To Use the Extended Transition Period false    
Entity Shell Company false    
Entity Public Float     $ 32,432,613
Entity Common Stock, Shares Outstanding   27,722,108  
Documents Incorporated by Reference [Text Block] None    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false